A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Evaluate the safety and tolerability of ZG19018 in Patients with KRAS G12C mutant advanced solid tumors.
Epistemonikos ID: 93281c863d7d54f8a350d4344a87e68363d77706
First added on: May 15, 2024